Cytokinetics, Incorporated

NasdaqGS:CYTK 주식 보고서

시가총액: US$5.8b

Cytokinetics 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?

최근 내부자 거래

NasdaqGS:CYTK 회사 또는 개인의 최근 내부자 거래
날짜가치이름엔티티역할공유최대 가격
12 Nov 24SellUS$60,936Fady MalikIndividual1,042US$58.48
30 Oct 24SellUS$103,860Fady MalikIndividual2,000US$51.93
15 Oct 24SellUS$108,400Fady MalikIndividual2,000US$54.20
01 Oct 24SellUS$104,220Fady MalikIndividual2,000US$52.11
17 Sep 24SellUS$113,520Fady MalikIndividual2,000US$56.76
03 Sep 24SellUS$118,830Fady MalikIndividual2,084US$57.02
20 Aug 24SellUS$112,460Fady MalikIndividual2,000US$56.23
06 Aug 24SellUS$107,400Fady MalikIndividual2,000US$53.70
23 Jul 24SellUS$114,040Fady MalikIndividual2,000US$57.02
10 Jul 24SellUS$311,245Robert BlumIndividual5,733US$54.29
09 Jul 24SellUS$111,780Fady MalikIndividual2,000US$55.89
05 Jul 24SellUS$13,816Robert HarringtonIndividual253US$54.61
01 Jul 24SellUS$621,575Robert BlumIndividual11,500US$54.05
25 Jun 24SellUS$107,480Fady MalikIndividual2,000US$53.74
17 Jun 24SellUS$1,183,391Robert BlumIndividual22,500US$52.60
11 Jun 24SellUS$125,469Fady MalikIndividual2,366US$53.03
10 Jun 24SellUS$104,140Muna BhanjiIndividual2,000US$52.07
03 Jun 24SellUS$635,978Robert WongIndividual13,011US$48.88
03 Jun 24SellUS$76,851Robert HarringtonIndividual1,580US$48.64
09 Apr 24SellUS$297,280Fady MalikIndividual4,000US$74.32

내부자 거래량

내부자 구매: CYTK insiders는 지난 3개월 동안 주식만 판매했습니다.

소유권 분석

CYTK 의 소유 구조는 어떻게 되나요?
소유자 유형공유 수소유권 비율
주 또는 정부46,1320.0332%
민간 기업105,8840.0763%
개인 내부자560,7650.404%
교육기관138,063,85899.5%

주식의 희석: 지난 해 주주 수는 희석되었으며, 총 발행 주식 수 20.4% 만큼 증가했습니다.

최대 주주

상위 25 주주가 회사의 85.81%를 소유하고 있습니다.
소유권이름공유현재 값변경 %포트폴리오 %
12.9%
BlackRock, Inc.
15,252,839US$748.9m3.95%0.01%
10.9%
T. Rowe Price Group, Inc.
12,854,932US$631.2m22.5%0.05%
10.3%
FMR LLC
12,093,859US$593.8m4.95%0.03%
9.97%
The Vanguard Group, Inc.
11,761,605US$577.5m2.83%0.01%
6.59%
Wellington Management Group LLP
7,774,970US$381.8m3.53%0.06%
5.47%
State Street Global Advisors, Inc.
6,458,324US$317.1m-1.38%0.01%
3.97%
Bank of America Corporation, Asset Management Arm
4,687,476US$230.2m10.5%0.06%
2.41%
Geode Capital Management, LLC
2,848,584US$139.9m4.01%0.01%
2.31%
RTW Investments, LP
2,721,158US$133.6m0%1.79%
1.98%
Polar Capital Holdings Plc
2,337,847US$114.8m-4.76%0.42%
1.78%
Tavistock Life Sciences
2,100,000US$103.1m0%6.52%
1.77%
Pictet Asset Management Limited
2,088,567US$102.5m18.1%0.09%
1.61%
Armistice Capital LLC
1,896,575US$93.1m-8.2%2.31%
1.59%
Marshall Wace LLP
1,873,701US$92.0m11.7%0.13%
1.49%
PFM Health Sciences, LP
1,757,192US$86.3m0%5.33%
1.41%
AllianceBernstein L.P.
1,661,014US$81.6m-11.6%0.02%
1.27%
Vestal Point Capital, LP
1,500,000US$73.6m-27.7%5.83%
1.13%
Northern Trust Global Investments
1,329,654US$65.3m3.64%0.01%
1.12%
Charles Schwab Investment Management, Inc.
1,321,391US$64.9m42.8%0.01%
1.03%
Westfield Capital Management Company, L.P.
1,212,886US$59.6m38.9%0.24%
1.03%
Melqart Asset Management (Uk) Ltd
1,212,258US$59.5m-27.7%5.68%
0.99%
Brown Advisory Incorporated
1,165,432US$57.2m52.9%0.07%
0.97%
Janus Henderson Group plc
1,143,830US$56.2m17.2%0.02%
0.94%
Sarissa Capital Management LP
1,110,000US$54.5m0%13.69%
0.93%
Pentwater Capital Management LP
1,100,000US$54.0m-1.7%0.98%